AOLS OTC
Aeolus Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -0.0%
5Y: -93.3%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$2M
-33.3% ▼
5Y CAGR: -15.5%
Gross Profit
-$805K
-102.3% ▼
Operating Income
-$3M
-24.6% ▼
Net Income
-$4M
-35.4% ▼
EPS (Diluted)
$-0.04
-100.0% ▼
EBITDA
-$3M
-24.6% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|---|---|---|---|---|
| Revenue | $7M | $4M | $10M | $3M | $2M |
| YoY Growth | +51.3% | -46.1% | +145.2% | -67.7% | -33.3% |
| Cost of Revenue | $0 | $3M | $7M | $4M | $3M |
| Gross Profit | $7M | $568K | $3M | -$398K | -$805K |
| Gross Margin | 100.0% | 14.5% | 27.7% | -12.8% | -38.8% |
| R&D Expenses | $6M | $3M | $7M | $4M | $3M |
| SG&A Expenses | $3M | $3M | $3M | $2M | $2M |
| Operating Expenses | $10M | $3M | $10M | $6M | $5M |
| Operating Income | -$2M | -$3M | -$80K | -$3M | -$3M |
| Operating Margin | -32.5% | -68.7% | -0.8% | -84.4% | -157.7% |
| Interest Expense | $0 | $0 | $0 | $2K | $285K |
| Income Before Tax | $2M | -$3M | -$80K | -$3M | -$4M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | $2M | -$3M | -$80K | -$3M | -$4M |
| Net Margin | 23.3% | -81.7% | -0.8% | -84.5% | -171.4% |
| EPS (Diluted) | $-0.03 | $-0.03 | $-0.00 | $-0.02 | $-0.04 |
| EBITDA | -$2M | -$3M | -$80K | -$3M | -$3M |
| Shares Outstanding | 73M | 107M | 135M | 136M | 149M |